SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-21-024079
Filing Date
2021-09-29
Accepted
2021-09-29 13:20:16
Documents
8

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 2100018
2 forms-1_001.jpg GRAPHIC 24391
3 forms-1_002.jpg GRAPHIC 22231
4 forms-1_003.jpg GRAPHIC 52118
5 forms-1_004.jpg GRAPHIC 21480
6 forms-1_005.jpg GRAPHIC 24474
7 fin1_001.jpg GRAPHIC 4435
8 finlogo_001.jpg GRAPHIC 4811
  Complete submission text file 0001493152-21-024079.txt   2313932
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-259771 | Film No.: 211290718
SIC: 2834 Pharmaceutical Preparations